24/05/20 -"Separating the wheat from the chaff"
MedTech, which has historically been a defensive sector, has once again stood its ground even as broader markets have been rattled by the pandemic. But, digging into the details throws up interesting trends: the resilience is underpinned by clear extremes. Hence, leveraging the right opportunities assumes a greater importance and is critical to outperformance. At the upcoming webinar, we will dissect these conflicting trends and share some interesting stock ideas that are best suited to win in a COVID-stricken world.
AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.
|Trading in corporate shares||NO|
|Advising of corporate (strategy, marketing, debt, etc)||NO|
|Research paid for by corporate||NO|
|Provision of corporate access paid for by corporate||NO|
|Link between and a banking entity||NO|
|Brokerage activity at AlphaValue||NO|